About ITSCC

In 2001, after noticing the need to better manage skin cancers in patients who received solid organ transplants, a core group of dermatologic surgeons from several institutions founded the International Transplant-Skin Cancer Collaborative (ITSCC).

A research project conducted at the Mayo Clinic focused on metastatic skin cancer in transplant patients. As part of the multi-center collaboration for the project, it became evident that many physicians were facing challenges treating skin cancers in organ transplant recipients.

An early collaborative group, under the name The North American Transplant Skin Cancer Collaborative, formed which was dedicated to finding optimal care for the skin and skin cancer of these patients. As membership became more diverse, including physicians and researchers from Central and South America, Australia, and other regions, the name was changed to ITSCC.

Today ITSCC is a dynamic, growing collaborative of clinicians and researchers from multiple disciplines dedicated to advancing the care and understanding of skin cancer in organ transplant recipients.